In this session, speakers will review the key aspects of the 340B program and then analyze the latest developments and what they mean for your contracts and pricing methodologies. Topics of discussion include:

• Diving into the key components of the 340B program
• Assessing HRSA’s new 340B administrative dispute resolution process
• Unpacking President Trump’s Executive Orders and what they mean for the 340B Program
  • E.g., HHS required to create new guidance on the rebate and discount model
• Distilling practical takeaways from the ongoing 340B lawsuits
• Analyzing the evolution of contract pharmacies, limits to access, and new state legislation
  • Knowing your compliance and disclosure obligations